Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Head and Neck Pathology
Erschienen in: Head and Neck Pathology 1/2016

01.03.2016 | Special Issue: Sinonasal Tract Pathology. Guest Editors: Justin Bishop, MD and Alessandro Franchi, MD

Update on Select Benign Mesenchymal and Meningothelial Sinonasal Tract Lesions

verfasst von: Lester D. R. Thompson, Julie C. Fanburg-Smith

Erschienen in: Head and Neck Pathology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Several benign and malignant mesenchymal and meningothelial lesions may preferentially affect or extend into the sinonasal tract. Glomangiopericytoma (GPC, formerly sinonasal-type hemangiopericytoma) is a specific tumor with a predilection to the sinonasal tract. Sinonasal tract polyps with stromal atypia (antrochoanal polyp) demonstrate unique histologic findings in the sinonasal tract. Juvenile nasopharyngeal angiofibroma (JNA) arises from specialized tissue in this location. Meningioma may develop as direct extension from its intracranial counterpart or as an ectopic tumor. Selected benign mesenchymal tumors may arise in the sinonasal tract and pose a unique differential diagnostic consideration, such as solitary fibrous tumor and GPC or lobular capillary hemangioma and JNA. Although benign and malignant vascular, fibrous, fatty, skeletal muscle, and nerve sheath tumors may occur in this location, this paper focuses on a highly select group of rare benign sinonasal tract tumors with their clinicopathological and molecular findings, and differential diagnosis.
Literatur
1.
2.
Gold JS, Antonescu CR, Hajdu C, et al. Clinicopathologic correlates of solitary fibrous tumors. Cancer. 2002;94:1057–68.CrossRefPubMed
3.
Suster S, Nascimento AG, Miettinen M, et al. Solitary fibrous tumors of soft tissue. A clinicopathologic and immunohistochemical study of 12 cases. Am J Surg Pathol. 1995;19:1257–66.CrossRefPubMed
4.
Miettinen M, Sarlomo-Rikala M, Kovatich AJ. Cell-type- and tumour-type-related patterns of bcl-2 reactivity in mesenchymal cells and soft tissue tumours. Virchows Arch. 1998;433:255–60.CrossRefPubMed
5.
Miettinen M, Paal E, Lasota J, et al. Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 32 cases. Am J Surg Pathol. 2002;26:301–11.CrossRefPubMed
6.
Thompson LD, Miettinen M, Wenig BM. Sinonasal-type hemangiopericytoma: a clinicopathologic and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation. Am J Surg Pathol. 2003;27:737–49.CrossRefPubMed
7.
Haller F, Bieg M, Moskalev EA, et al. Recurrent mutations within the amino-terminal region of beta-catenin are probable key molecular driver events in sinonasal hemangiopericytoma. Am J Pathol. 2015;185:563–71.CrossRefPubMed
8.
Lasota J, Felisiak-Golabek A, Aly FZ, et al. Nuclear expression and gain-of-function beta-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker. Mod Pathol. 2015;28:715–20.CrossRefPubMed
9.
Fletcher CD. Hemangiopericytoma–a dying breed? Reappraisal of an “entity” and its variant. A hypothesis. Curr Diagn Pathol. 1994;1:19–23.CrossRef
10.
Granter SR, Badizadegan K, Fletcher CD. Myofibromatosis in adults, glomangiopericytoma, and myopericytoma: a spectrum of tumors showing perivascular myoid differentiation. Am J Surg Pathol. 1998;22:513–25.CrossRefPubMed
11.
Catalano PJ, Brandwein M, Shah DK, et al. Sinonasal hemangiopericytomas: a clinicopathologic and immunohistochemical study of seven cases. Head Neck. 1996;18:42–53.CrossRefPubMed
12.
Compagno J, Hyams VJ. Hemangiopericytoma-like intranasal tumors. A clinicopathologic study of 23 cases. Am J Clin Pathol. 1976;66:672–83.PubMed
13.
Billings KR, Fu YS, Calcaterra TC, et al. Hemangiopericytoma of the head and neck. Am J Otolaryngol. 2000;21:238–43.CrossRefPubMed
14.
el Naggar AK, Batsakis JG, Garcia GM, et al. Sinonasal hemangiopericytomas. A clinicopathologic and DNA content study. Arch Otolaryngol Head Neck Surg. 1992;118:134–7.CrossRefPubMed
15.
Brandwein-Gensler M, Siegal GP. Striking pathology gold: a singular experience with daily reverberations: sinonasal hemangiopericytoma (glomangiopericytoma) and oncogenic osteomalacia. Head Neck Pathol. 2012;6:64–74.PubMedCentralCrossRefPubMed
16.
Marianowski R, Wassef M, Herman P, et al. Nasal haemangiopericytoma: report of two cases with literature review. J Laryngol Otol. 1999;113:199–206.PubMed
17.
Eichhorn JH, Dickersin GR, Bhan AK, et al. Sinonasal hemangiopericytoma. A reassessment with electron microscopy, immunohistochemistry, and long-term follow-up. Am J Surg Pathol. 1990;14:856–66.CrossRefPubMed
18.
Kowalski PJ, Paulino AF. Proliferation index as a prognostic marker in hemangiopericytoma of the head and neck. Head Neck. 2001;23:492–6.CrossRefPubMed
19.
Enzinger FM, Smith BH. Hemangiopericytoma. An analysis of 106 cases. Hum Pathol. 1976;7:61–82.CrossRefPubMed
20.
Folpe AL, Devaney K, Weiss SW. Lipomatous hemangiopericytoma: a rare variant of hemangiopericytoma that may be confused with liposarcoma. Am J Surg Pathol. 1999;23:1201–7.CrossRefPubMed
21.
Nielsen GP, Dickersin GR, Provenzal JM, et al. Lipomatous hemangiopericytoma. A histologic, ultrastructural and immunohistochemical study of a unique variant of hemangiopericytoma. Am J Surg Pathol. 1995;19:748–56.CrossRefPubMed
22.
Guillou L, Gebhard S, Coindre JM. Lipomatous hemangiopericytoma: a fat-containing variant of solitary fibrous tumor? Clinicopathologic, immunohistochemical, and ultrastructural analysis of a series in favor of a unifying concept. Hum Pathol. 2000;31:1108–15.CrossRefPubMed
23.
Agaimy A, Barthelmeß S, Boltze C, et al. Phenotypical and molecular distinctness of sinonasal haemangiopericytoma compared to solitary fibrous tumour of the sinonasal tract. Histopathology. 2014;65:667–73.CrossRefPubMed
24.
Gengler C, Guillou L. Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology. 2006;48:63–74.CrossRefPubMed
25.
Nappi O, Ritter JH, Pettinato G, et al. Hemangiopericytoma: histopathological pattern or clinicopathologic entity? Semin Diagn Pathol. 1995;12:221–32.PubMed
26.
Porter PL, Bigler SA, McNutt M, et al. The immunophenotype of hemangiopericytomas and glomus tumors, with special reference to muscle protein expression: an immunohistochemical study and review of the literature. Mod Pathol. 1991;4:46–52.PubMed
27.
28.
Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8:387–98.CrossRefPubMed
29.
Huss S, Nehles J, Binot E. β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis. Histopathology. 2013;62:294–304.CrossRefPubMed
30.
Fukunaga M, Ushigome S, Nomura K, et al. Solitary fibrous tumor of the nasal cavity and orbit. Pathol Int. 1995;45:952–7.CrossRefPubMed
31.
Witkin GB, Rosai J. Solitary fibrous tumor of the upper respiratory tract. A report of six cases. Am J Surg Pathol. 1991;15:842–8.CrossRefPubMed
32.
Zukerberg LR, Rosenberg AE, Randolph G, et al. Solitary fibrous tumor of the nasal cavity and paranasal sinuses. Am J Surg Pathol. 1991;15:126–30.CrossRefPubMed
33.
Kempson RL, Fletcher CDM, Evans HL, et al. Fibrous and myofibroblastic tumors. In: Kempson RL, Fletcher CDM, Evans HL, Hendrickson MR, Sibley RK, editors. Atlas of tumor pathology: tumors of the soft tissues. Bethesda: Armed Forces Institute of Pathology; 2001. p. 23–112.
34.
Cox DP, Daniels T, Jordan RC. Solitary fibrous tumor of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:79–84.CrossRefPubMed
35.
Rakheja D, Molberg KH, Roberts CA. Immunohistochemical expression of beta-catenin in solitary fibrous tumors. Arch Pathol Lab Med. 2005;129:776–9.PubMed
36.
Chmielecki J, Crago AM, Rosenberg M. Whole exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet. 2013;45:131–2.PubMedCentralCrossRefPubMed
37.
Furusato E, Valenzuela IA, Fanburg-Smith JC, et al. Orbital solitary fibrous tumor: encompassing terminology for hemangiopericytoma, giant cell angiofibroma, and fibrous histiocytoma of the orbit: reappraisal of 41 cases. Hum Pathol. 2011;42:120–8.CrossRefPubMed
38.
Li Z, Wang J, Zhu Q, et al. Huge solitary fibrous tumor of the pleura with hypoglycemia and hypokalemia: a case report. Ann Thorac Cardiovasc Surg. 2014;20:165–8.CrossRefPubMed
39.
Baldi GG, Stacchiotti S, Mauro V, et al. Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients. Clin Sarcoma Res. 2013;3:4.PubMedCentralCrossRefPubMed
40.
Xue Y, Chai G, Xiao F, et al. Post-operative radiotherapy for the treatment of malignant solitary fibrous tumor of the nasal and paranasal area. Jpn J Clin Oncol. 2014;44:926–31.CrossRefPubMed
41.
42.
Demicco EG, Park MS, Araujo DM, et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol. 2012;25:1298–306.CrossRefPubMed
43.
44.
Stacchiotti S, Tortoreto M, Baldi GG, et al. Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour. Eur J Cancer. 2014;50:3021–8.CrossRefPubMed
45.
Tazzari M, Negri T, Rini F, et al. Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy. Br J Cancer. 2014;111:1350–62.PubMedCentralCrossRefPubMed
46.
Yamada Y, Kohashi K, Fushimi F, et al. Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors. Cancer. 2014;120:864–76.CrossRefPubMed
47.
Mosquera JM, Fletcher CD. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component–is this dedifferentiated SFT? Am J Surg Pathol. 2009;33:1314–21.CrossRefPubMed
48.
Doyle LA, Vivero M, Fletcher CD, et al. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol. 2014;27:390–5.CrossRefPubMed
49.
Yoshida A, Tsuta K, Ohno M, et al. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol. 2014;38:552–9.CrossRefPubMed
50.
Demicco EG, Harms PW, Patel RM, et al. Extensive survey of STAT6 expression in a large series of mesenchymal tumors. Am J Clin Pathol. 2015;143:672–82.CrossRefPubMed
51.
Mohajeri A, Tayebwa J, Collin A, et al. Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor. Genes Chromosomes Cancer. 2013;52:873–86.CrossRefPubMed
52.
Demicco EG, Wani K, Fox PS, et al. Histologic variability in solitary fibrous tumors reflects angiogenic and growth factor signaling pathway alterations. Hum Pathol. 2015;46:1015–26.CrossRefPubMed
53.
Akaike K, Kurisaki-Arakawa A, Hara K, et al. Distinct clinicopathological features of NAB2-STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential. Hum Pathol. 2015;46:347–56.CrossRefPubMed
54.
55.
Balikci HH, Ozkul MH, Uvacin O, et al. Antrochoanal polyposis: analysis of 34 cases. Eur Arch Otorhinolaryngol. 2013;270:1651–4.CrossRefPubMed
56.
Frosini P, Picarella G, De CE. Antrochoanal polyp: analysis of 200 cases. Acta Otorhinolaryngol Ital. 2009;29:21–6.PubMedCentralPubMed
57.
Ozcan C, Zeren H, Talas DU, et al. Antrochoanal polyp: a transmission electron and light microscopic study. Eur Arch Otorhinolaryngol. 2005;262:55–60.CrossRefPubMed
58.
Mahfouz ME, Elsheikh MN, Ghoname NF. Molecular profile of the antrochoanal polyp: up-regulation of basic fibroblast growth factor and transforming growth factor beta in maxillary sinus mucosa. Am J Rhinol. 2006;20:466–70.CrossRefPubMed
59.
Montague ML, McGarry GW. Familial antrochoanal polyposis–a case report. Eur Arch Otorhinolaryngol. 2004;261:507–8.CrossRefPubMed
60.
Nikakhlagh S, Rahim F, Saki N, et al. Antrochoanal polyps: report of 94 cases and review the literature. Niger J Med. 2012;21:156–9.PubMed
61.
Aydin O, Keskin G, Ustundag E, et al. Choanal polyps: an evaluation of 53 cases. Am J Rhinol. 2007;21:164–8.CrossRefPubMed
62.
Sarafraz M, Niazi A, Araghi S. The prevalence of clinical presentations and pathological characteristics of antrochoanal polyp. Niger J Med. 2015;24:12–6.PubMed
63.
Skladzien J, Litwin JA, Nowogrodzka-Zagorska M, et al. Morphological and clinical characteristics of antrochoanal polyps: comparison with chronic inflammation-associated polyps of the maxillary sinus. Auris Nasus Larynx. 2001;28:137–41.CrossRefPubMed
64.
Atighechi S, Baradaranfar MH, Karimi G, et al. Antrochoanal polyp: a comparative study of endoscopic endonasal surgery alone and endoscopic endonasal plus mini-Caldwell technique. Eur Arch Otorhinolaryngol. 2009;266:1245–8.CrossRefPubMed
65.
Chung SK, Chang BC, Dhong HJ. Surgical, radiologic, and histologic findings of the antrochoanal polyp. Am J Rhinol. 2002;16:71–6.PubMed
66.
Mallick S, Benson R, Bhasker S, et al. Long-term treatment outcomes of juvenile nasopharyngeal angiofibroma treated with radiotherapy. Acta Otorhinolaryngol Ital. 2015;35:75–9.PubMedCentralPubMed
67.
Carlos R, Thompson LD, Netto AC, et al. Epstein-Barr virus and human herpes virus-8 are not associated with juvenile nasopharyngeal angiofibroma. Head Neck Pathol. 2008;2:145–9.PubMedCentralCrossRefPubMed
68.
Silveira SM, Custodio Domingues MA, Butugan O, et al. Tumor microenvironmental genomic alterations in juvenile nasopharyngeal angiofibroma. Head Neck. 2012;34:485–92.CrossRefPubMed
69.
Maniglia MP, Ribeiro ME, Costa NM, et al. Molecular pathogenesis of juvenile nasopharyngeal angiofibroma in brazilian patients. Pediatr Hematol Oncol. 2013;30:616–22.CrossRefPubMed
70.
Renkonen S, Kankainen M, Hagstrom J, et al. Systems-level analysis of clinically different phenotypes of juvenile nasopharyngeal angiofibromas. Laryngoscope. 2012;122:2728–35.CrossRefPubMed
71.
Schiff M, Gonzalez AM, Ong M, et al. Juvenile nasopharyngeal angiofibroma contain an angiogenic growth factor: basic FGF. Laryngoscope. 1992;102:940–5.CrossRefPubMed
72.
Smith SC, Patel RM, Lucas DR, et al. Sinonasal lobular capillary hemangioma: a clinicopathologic study of 34 cases characterizing potential for local recurrence. Head Neck Pathol. 2013;7:129–34.PubMedCentralCrossRefPubMed
73.
Dyduch G, Okon K, Mierzynski W. Benign vascular proliferations–an immunohistochemical and comparative study. Pol J Pathol. 2004;55:59–64.PubMed
74.
Yuan K, Lin MT. The roles of vascular endothelial growth factor and angiopoietin-2 in the regression of pregnancy pyogenic granuloma. Oral Dis. 2004;10:179–85.CrossRefPubMed
75.
Nelson BL, Thompson LD. Sinonasal tract angiosarcoma: a clinicopathologic and immunophenotypic study of 10 cases with a review of the literature. Head Neck Pathol. 2007;1:1–12.PubMedCentralCrossRefPubMed
76.
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. World health organization classification of tumours of the central nervous system. 4th ed. Lyon: IARC Press; 2007.
77.
Shibuya M. Pathology and molecular genetics of meningioma: recent advances. Neurol Med Chir (Tokyo). 2015;55:14–27.CrossRef
78.
Perzin KH, Pushparaj N. Nonepithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx. A clinicopathologic study. XIII: Meningiomas. Cancer. 1984;54:1860–9.CrossRefPubMed
79.
80.
Thompson LD, Gyure KA. Extracranial sinonasal tract meningiomas: a clinicopathologic study of 30 cases with a review of the literature. Am J Surg Pathol. 2000;24:640–50.CrossRefPubMed
81.
Moulin G, Coatrieux A, Gillot JC, et al. Plaque-like meningioma involving the temporal bone, sinonasal cavities and both parapharyngeal spaces: CT and MRI. Neuroradiology. 1994;36:629–31.CrossRefPubMed
82.
Kaley TJ, Wen P, Schiff D, et al. Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma. Neuro Oncol. 2015;17:116–21.PubMedCentralCrossRefPubMed
83.
Perry A, Stafford SL, Scheithauer BW, et al. Meningioma grading. An analysis of histologic parameters. Am J Surg Pathol. 1997;21:1455–65.CrossRefPubMed
84.
85.
Perry A, Scheithauer BW, Stafford SL, et al. “Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer. 1999;85:2046–56.PubMed
86.
Schweizer L, Koelsche C, Sahm F, et al. Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol. 2013;125:651–8.CrossRefPubMed
87.
Miller R, DeCandio ML, Xon-Mah Y, et al. Molecular targets and treatment of meningioma. J Neurol Neurosurg. 2014;1:10001011.
88.
Domingues P, Gonzalez-Tablas M, Otero A, et al. Genetic/molecular alterations of meningiomas and the signaling pathways targeted. Oncotarget. 2015;6:10671–88.PubMedCentralCrossRefPubMed
89.
Gusella JF, Ramesh V, MacCollin M, et al. Merlin: the neurofibromatosis 2 tumor suppressor. Biochim Biophys Acta. 1999;1423:M29–36.PubMed
90.
Stawski R, Piaskowski S, Stoczynska-Fidelus E, et al. Reduced expression of ELAVL4 in male meningioma patients. Brain Tumor Pathol. 2013;30:160–6.CrossRefPubMed
91.
92.
Thompson LDR, Wieneke JA, Miettinen M. Sinonasal tract melanomas: A clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol. 2003;27:594–611.CrossRefPubMed
93.
Wenig BM, Vinh TN, Smirniotopoulos JG, et al. Aggressive psammomatoid ossifying fibromas of the sinonasal region. A clinicopathologic study of a distinct group of fibro-osseous lesions. Cancer. 1995;76:1155–65.CrossRefPubMed
Metadaten
Titel
Update on Select Benign Mesenchymal and Meningothelial Sinonasal Tract Lesions
verfasst von
Lester D. R. Thompson
Julie C. Fanburg-Smith
Publikationsdatum
01.03.2016
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 1/2016
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-016-0697-6

Weitere Artikel der Ausgabe 1/2016

Head and Neck Pathology 1/2016 Zur Ausgabe

Special Issue: Sinonasal Tract Pathology. Guest Editors: Justin Bishop, MD and Alessandro Franchi, MD

Hematolymphoid Lesions of the Sinonasal Tract

Special Issue: Sinonasal Tract Pathology. Guest Editors: Justin Bishop, MD and Alessandro Franchi, MD

Sinonasal Squamous Cell Carcinoma: A Review with Emphasis on Emerging Histologic Subtypes and the Role of Human Papillomavirus

Special Issue: Sinonasal Tract Pathology. Guest Editors: Justin Bishop, MD and Alessandro Franchi, MD

Sinonasal Adenocarcinoma: Update on Classification, Immunophenotype and Molecular Features

Special Issue: Sinonasal Tract Pathology. Guest Editors: Justin Bishop, MD and Alessandro Franchi, MD

Non-infectious Inflammatory Lesions of the Sinonasal Tract

Special Issue: Sinonasal Tract Pathology. Guest Editors: Justin Bishop, MD and Alessandro Franchi, MD

Low-Grade Epithelial Proliferations of the Sinonasal Tract

Special Issue: Sinonasal Tract Pathology. Guest Editors: Justin Bishop, MD and Alessandro Franchi, MD

An Update on Sinonasal Round Cell Undifferentiated Tumors

Neu im Fachgebiet Pathologie

01.04.2024 | Forensische Traumatologie | CME

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Open Access 22.02.2024 | Pathologie | Originalien

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

21.02.2024 | Thrombozytopenie | CME

Knochenmarkhistologie bei Zytopenien
Beitrag zur hämatologischen Differenzialdiagnostik

Open Access 21.02.2024 | Fettleber | Originalien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien
Automatische Quantifizierung von Leberverfettung